13F-HR filed by ACUTA CAPITAL PARTNERS, LLC
ACUTA CAPITAL PARTNERS, LLC filed this 13F-HR for the quarter ended 2016-12-31, filed 2017-02-13, with 50 holding rows worth $268,917,000.
- Accession
- 0001493152-17-001423
- Filer
- CIK 1582844
- Filed
- 2017-02-13
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q4 2016
A holdings report, 50 entries on the cover page, a total value of $268,917,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $268,917,000 with VALUE read as thousands by filing date, 13F file number 028-16527. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| VERACYTE INC COM | 92337F107 | Stock | 3,513,161 | $27,192,000 | thousands by filing date | |
| Lion Biotechnologies | 53619R102 | COM | 3,809,944 | $26,479,000 | thousands by filing date | |
| IRIDEX CORP | 462684101 | COM | 1,554,146 | $21,851,000 | thousands by filing date | |
| IMMUNOMEDICS INC | 452907108 | COM | 4,700,000 | $17,249,000 | thousands by filing date | |
| NEURODERM LTD | M74231107 | ORD SHS | 665,944 | $14,784,000 | thousands by filing date | |
| EDGE THERAPEUTICS INC | 279870109 | COM | 1,040,265 | $13,003,000 | thousands by filing date | |
| ASSEMBLY BIOSCIENCES INC | 045396108 | COM | 976,599 | $11,866,000 | thousands by filing date | |
| ASCENDIS PHARMA A/S DKK 1.0 AD | 04351P101 | SPONSORED ADR | 575,309 | $11,644,000 | thousands by filing date | |
| IMMUNOMEDICS INC | 452907AK4 | NOTE 4.750 2/1 | 10,500,000 | $10,395,000 | thousands by filing date | principal |
| ACLARIS THERAPEUTICS INC COM | 00461U105 | Stock | 372,753 | $10,117,000 | thousands by filing date | |
| iShares Russell 2000 ETF | 464287655 | SHS | 70,000 | $9,440,000 | thousands by filing date | put |
| ACADIA PHARMACEUTICALS INC | 004225108 | COM | 300,000 | $8,652,000 | thousands by filing date | |
| CHEMBIO DIAGNOSTICS | 163572209 | COM | 1,150,925 | $7,826,000 | thousands by filing date | |
| AKEBIA THERAPEUTICS INC | 00972D105 | COMMON STOCK | 698,825 | $7,275,000 | thousands by filing date | |
| OXFORD IMMUNOTEC GLOBAL PLC | G6855A103 | ORD SHS | 470,834 | $7,039,000 | thousands by filing date | |
| MARVELL TECHNOLOGY GROUP LTD | G5876H105 | ORD | 500,000 | $6,935,000 | thousands by filing date | |
| CAS MED SYS INC | 124769209 | COM | 4,179,838 | $6,730,000 | thousands by filing date | |
| RA PHARMACEUTICALS INC | 74933V108 | COM | 377,909 | $5,740,000 | thousands by filing date | |
| GW PHARMACEUTICALS PLC | 36197T103 | ADS | 40,000 | $4,470,000 | thousands by filing date | |
| NABRIVA THERAPEUTICS AG | 62957M104 | SPONSORED ADR | 706,383 | $4,210,000 | thousands by filing date | |
| WEBMD HEALTH CORP | 94770V102 | COM | 80,000 | $3,966,000 | thousands by filing date | |
| DBV TECHNOLOGIES S A | 23306J101 | ADR | 91,898 | $3,228,000 | thousands by filing date | |
| VERACYTE INC COM | 92337F107 | Stock | 375,000 | $2,903,000 | thousands by filing date | call |
| DERMIRA INC | 24983L104 | COM | 88,500 | $2,684,000 | thousands by filing date | |
| VANDA PHARMACEUTICALS INC | 921659108 | COM | 162,600 | $2,593,000 | thousands by filing date | |
| SOCIETAL CDMO INC | 75629F109 | COM | 300,000 | $2,418,000 | thousands by filing date | |
| AURINIA PHARMACEUTICALS INC COM | 05156V102 | Stock | 1,000,000 | $2,100,000 | thousands by filing date | |
| AERIE PHARMACEUTICALS INC | 00771V108 | COM | 50,000 | $1,893,000 | thousands by filing date | |
| CLEARSIDE BIOMEDICAL INC | 185063104 | COM | 175,000 | $1,565,000 | thousands by filing date | |
| ZIMMER BIOMET HOLDINGS INC COM | 98956P102 | Stock | 15,000 | $1,548,000 | thousands by filing date | |
| SAREPTA THERAPEUTICS INC | 803607100 | COM | 50,000 | $1,372,000 | thousands by filing date | put |
| ESSA PHARMA INC | 29668H104 | COM | 605,300 | $1,330,000 | thousands by filing date | |
| EXELIXIS INC COM | 30161Q104 | Stock | 80,000 | $1,193,000 | thousands by filing date | put |
| ALIMERA SCIENCES INC | 016259103 | COM | 974,318 | $1,052,000 | thousands by filing date | |
| Lion Biotechnologies | 53619R102 | COM | 150,000 | $1,043,000 | thousands by filing date | call |
| BIOCRYST PHARMACEUTICALS INC COM | 09058V103 | Stock | 150,000 | $950,000 | thousands by filing date | |
| ROCKWELL MED INC | 774374102 | COM | 140,000 | $917,000 | thousands by filing date | put |
| AMICUS THERAPEUTICS INC | 03152W109 | COM | 145,300 | $722,000 | thousands by filing date | |
| SPECTRANETICS CORP | 84760C107 | COM | 27,500 | $674,000 | thousands by filing date | |
| BIOCRYST PHARMACEUTICALS INC COM | 09058V103 | Stock | 99,000 | $627,000 | thousands by filing date | call |
| ARDELYX INC | 039697107 | COM | 26,891 | $382,000 | thousands by filing date | |
| IMMUNOMEDICS INC | 452907108 | COM | 100,000 | $367,000 | thousands by filing date | call |
| ASSEMBLY BIOSCIENCES INC | 045396108 | COM | 10,000 | $122,000 | thousands by filing date | call |
| ONCOBIOLOGICS INC | 68235M105 | COM | 29,082 | $88,000 | thousands by filing date | |
| ENDOLOGIX INC | 29266SAA4 | NOTE 2.250%12/1 | 96,000 | $86,000 | thousands by filing date | principal |
| ONCOBIOLOGICS INC | 68235M121 | *W EXP 05/18/201 | 96,833 | $76,000 | thousands by filing date | |
| MANNKIND CORP | 56400P201 | COM | 90,000 | $58,000 | thousands by filing date | put |
| PLURISTEM THERAPEUTICS INC | 72940R102 | COM | 21,100 | $30,000 | thousands by filing date | put |
| ONCOBIOLOG-CW17A | 68235M113 | EQUITY WRT | 96,833 | $18,000 | thousands by filing date | |
| OHR PHARMACEUTICAL INC | 67778H200 | COMMON STOCK | 10,000 | $15,000 | thousands by filing date | call |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001493152-17-001423 | this filing | 2017-02-13 | acceptance time not in the bulk data set |